The deadline on US pharmaceutical tariffs has been dramatically brought forward, in the latest escalation of Donald Trump's ...

President Donald Trump's tariffs tanked markets and unleashed recession forecasts when the president unveiled sweeping levies ...

President Trump and his administration have been studying new sectoral tariffs that could cover a broad part of the American ...

Find insight on European pharmaceutical sector corporate bonds, GSK and more in the latest Market Talks covering Health Care.

Amgen Inc. (NASDAQ:AMGN) is one of the high-margin pharma stocks to buy now. HSBC has lowered its price target on Amgen Inc.

President Trump is readying plans for industry-specific tariffs to kick in alongside his country-by-country duties in two ...

The average consumer could pay 75 percent more for a marketplace plan, according to a KFF analysis, driven by the expiration ...

The expiration of the enhanced ACA premium subsidies at the end of this year is prompting many insurers to hike rates by an ...

Despite former President Donald Trump’s threat of a 200% tariff on imported drugs during a cabinet meeting, pharmaceutical investors have shown surprisingly positive sentiment this week. Despite ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...